guides · production workflows · learn / editorial
Learn AI Viral as a repeatable production method.
“ai viral” is approached through production production method: start with a rights-cleared representative source and a written acceptance brief, define the visible change and protected details, then compare the result against a inspectable visual-production brief and evidence-aware handoff. The channel owner checks reference integrity in the revision log before final approval.
Learn AI Viral through a production Review focus: decision memo, legal reviewer, editability, and evidence-backed brief; keep viral evidence separate from viral assumptions.
Frame the learning objective and finished handoff
Decide what a reader should be able to prepare after learning AI Viral, which prior knowledge is assumed, and what a valid result looks like within production workflows. For this section 1, save a shot contract; have the post supervisor review temporal stability; record the failed case as well as the accepted one; and do not advance it beyond a rights-cleared draft until the named limitation is resolved. Keep viral evidence separate from viral assumptions.
Turn the topic into a repeatable method
Move from definition to a small practice sequence, then review the result against explicit craft, rights, and delivery checks. Keep vendor-specific behavior outside the method unless a source verifies it. For this section 2, save a continuity sheet; have the technical reviewer review message clarity; record the failed case as well as the accepted one; and do not advance it beyond a rights-cleared draft until the named limitation is resolved. Keep viral evidence separate from viral assumptions.
Practice one decision at a time
Start with a compact brief, create a single controlled variation, and compare it with the original intent. Add complexity only after the reader can explain why the change improved clarity, continuity, or delivery readiness. For this section 3, save a evidence ledger; have the media owner review reference integrity; record the failed case as well as the accepted one; and do not advance it beyond a rights-cleared draft until the named limitation is resolved. Keep viral evidence separate from viral assumptions.
- Preserve authorized source material — record prompt brief, product specialist, camera intent, and evidence-backed brief; keep viral evidence separate from viral assumptions.
- Annotate the reason for each revision — record evidence ledger, channel owner, action readability, and evidence-backed brief; keep viral evidence separate from viral assumptions.
- Keep product-specific steps dated and sourced — record continuity sheet, post supervisor, temporal stability, and editorial approval; keep viral evidence separate from viral assumptions.
Review craft, truthfulness, and delivery separately
Check narrative and visual quality first, factual and identity claims second, then format and handoff requirements. Separating these passes makes gaps visible and prevents polished output from bypassing evidence review. For this section 4, save a test worksheet; have the product specialist review identity consent; record the failed case as well as the accepted one; and do not advance it beyond a rights-cleared draft until the named limitation is resolved. Keep viral evidence separate from viral assumptions.
Keep the evidence ledger attached to the decision
Partial evidence was supplied, but it does not establish product support or a complete capability, customer, or performance claim. Record the source, verification date, claim scope, unresolved gap, and the decision that the evidence can support. Search demand must never be reused as capability proof. For this section 5, save a annotated source board; have the fact checker review licensing; record the failed case as well as the accepted one; and do not advance it beyond a rights-cleared draft until the named limitation is resolved. Keep viral evidence separate from viral assumptions.
Separate topic fit from product proof
A dated, user-provided competitor-gap export supports only the decision to cover “ai viral.” It does not prove audience demand, SEELE capability, third-party behavior, commercial value, or a likely outcome. Verify product-specific statements against current first-party documentation and a recorded representative test. For this source review, save a delivery checklist; have the creative producer review revision control; record the failed case as well as the accepted one; and do not advance it beyond a shot approval until the named limitation is resolved. Keep viral evidence separate from viral assumptions.